ALGN
Price
$126.16
Change
+$1.28 (+1.02%)
Updated
Sep 26, 12:57 PM (EDT)
Capitalization
9.05B
33 days until earnings call
CZMWY
Price
$49.86
Change
-$3.77 (-7.03%)
Updated
Sep 25 closing price
Capitalization
4.73B
76 days until earnings call
Interact to see
Advertisement

ALGN vs CZMWY

Header iconALGN vs CZMWY Comparison
Open Charts ALGN vs CZMWYBanner chart's image
Align Technology
Price$126.16
Change+$1.28 (+1.02%)
Volume$200
Capitalization9.05B
Carl Zeiss Meditec AG
Price$49.86
Change-$3.77 (-7.03%)
Volume$6.6K
Capitalization4.73B
ALGN vs CZMWY Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. CZMWY commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Buy and CZMWY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ALGN: $124.88 vs. CZMWY: $49.86)
Brand notoriety: ALGN: Notable vs. CZMWY: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 89% vs. CZMWY: 150%
Market capitalization -- ALGN: $9.05B vs. CZMWY: $4.73B
ALGN [@Pharmaceuticals: Other] is valued at $9.05B. CZMWY’s [@Pharmaceuticals: Other] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileCZMWY’s FA Score has 1 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • CZMWY’s FA Score: 1 green, 4 red.
According to our system of comparison, CZMWY is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 4 TA indicator(s) are bullish while CZMWY’s TA Score has 2 bullish TA indicator(s).

  • ALGN’s TA Score: 4 bullish, 3 bearish.
  • CZMWY’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ALGN is a better buy in the short-term than CZMWY.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а -5.80% price change this week, while CZMWY (@Pharmaceuticals: Other) price change was -5.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.30%. For the same industry, the average monthly price growth was -3.33%, and the average quarterly price growth was +8.49%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

CZMWY is expected to report earnings on Dec 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($9.05B) has a higher market cap than CZMWY($4.73B). CZMWY has higher P/E ratio than ALGN: CZMWY (24.68) vs ALGN (21.09). CZMWY YTD gains are higher at: 5.963 vs. ALGN (-40.108). ALGN has higher annual earnings (EBITDA): 793M vs. CZMWY (226M). ALGN has more cash in the bank: 901M vs. CZMWY (51.5M). ALGN has less debt than CZMWY: ALGN (123M) vs CZMWY (147M). ALGN has higher revenues than CZMWY: ALGN (3.97B) vs CZMWY (2.18B).
ALGNCZMWYALGN / CZMWY
Capitalization9.05B4.73B191%
EBITDA793M226M351%
Gain YTD-40.1085.963-673%
P/E Ratio21.0924.6885%
Revenue3.97B2.18B182%
Total Cash901M51.5M1,750%
Total Debt123M147M84%
FUNDAMENTALS RATINGS
ALGN vs CZMWY: Fundamental Ratings
ALGN
CZMWY
OUTLOOK RATING
1..100
533
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6678
PRICE GROWTH RATING
1..100
6563
P/E GROWTH RATING
1..100
9361
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CZMWY's Valuation (30) in the null industry is somewhat better than the same rating for ALGN (73) in the Medical Specialties industry. This means that CZMWY’s stock grew somewhat faster than ALGN’s over the last 12 months.

CZMWY's Profit vs Risk Rating (100) in the null industry is in the same range as ALGN (100) in the Medical Specialties industry. This means that CZMWY’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's SMR Rating (66) in the Medical Specialties industry is in the same range as CZMWY (78) in the null industry. This means that ALGN’s stock grew similarly to CZMWY’s over the last 12 months.

CZMWY's Price Growth Rating (63) in the null industry is in the same range as ALGN (65) in the Medical Specialties industry. This means that CZMWY’s stock grew similarly to ALGN’s over the last 12 months.

CZMWY's P/E Growth Rating (61) in the null industry is in the same range as ALGN (93) in the Medical Specialties industry. This means that CZMWY’s stock grew similarly to ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNCZMWY
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 22 days ago
73%
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEFAX13.25N/A
N/A
MassMutual Mid Cap Growth A
RSIYX17.34N/A
N/A
Victory RS Investors Y
MSGRX13.35N/A
N/A
Meridian Small Cap Growth Institutional
PBQQX26.38N/A
N/A
PGIM Jennison Blend R6
CEUAX62.61-0.52
-0.82%
American Funds EUPAC 529-A

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been closely correlated with BAX. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALGN jumps, then BAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
-2.57%
BAX - ALGN
71%
Closely correlated
-3.77%
NVST - ALGN
53%
Loosely correlated
-2.73%
LUNG - ALGN
52%
Loosely correlated
-3.39%
SAUHY - ALGN
49%
Loosely correlated
-1.96%
ILMN - ALGN
48%
Loosely correlated
-2.35%
More

CZMWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CZMWY has been loosely correlated with SMMNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CZMWY jumps, then SMMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWY
1D Price
Change %
CZMWY100%
-7.03%
SMMNY - CZMWY
44%
Loosely correlated
-4.33%
SONVY - CZMWY
38%
Loosely correlated
-4.07%
SAUHY - CZMWY
37%
Loosely correlated
-1.96%
ALGN - CZMWY
37%
Loosely correlated
-2.57%
ALC - CZMWY
36%
Loosely correlated
-2.35%
More